Skip to main content

Web Exclusives

FDA Approvals, In the News, Select Drug Profiles

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL

Select Drug Profiles

Tavalisse (Fostamatinib Disodium Hexahydrate) First Spleen Tyrosine Kinase Inhibitor Approved for Chronic Immune Thrombocytopenia

Breast Cancer, FDA Approvals, In the News, Select Drug Profiles

FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer

FDA Approvals, In the News, Select Drug Profiles

Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation

Select Drug Profiles

Daurismo (Glasdegib) Approved, in Combination with Low-Dose Cytarabine, for Newly Diagnosed Acute Myeloid Leukemia in Older Adults or Those Unfit for Intensive Chemotherapy

Select Drug Profiles

Talzenna (Talazoparib) New PARP Inhibitor Approved for the Treatment of HER2-Negative Advanced Breast Cancer with Germline BRCA Mutation

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma

Select Drug Profiles

Braftovi (Encorafenib) plus Mektovi (Binimetinib) Third BRAF/MEK Inhibition Combination Approved for Metastatic Melanoma with BRAF Mutation

FDA Approvals, In the News, Select Drug Profiles

April 16, 2019 – FDA Approvals, News & Updates

16
17
18
19
20
21
22

Page 19 of 37
Results 181 - 190 of 366